
Acta Neuropharmacologica››2012,Vol. 2››Issue (3): 7-14.
Previous ArticlesNext Articles
DONG Xiao-hua1, MENG Xian-yong2, ZHANG Li1, YANG Jian-ming1
Online:2012-06-26Published:2013-12-25Contact:张力,男,教授,硕士生导师;研究方向:神经药理学;Tel:+86-0313-4029188,E-mail:zmczl@hotmail.comAbout author:董晓华,女,副教授,博士;研究方向:神经药理学;Tel:+86-0313-4029305,E-mail:hbdxh76@163.comSupported by:
河北省卫生厅资助项目(No.20090183),河北省科技厅资助项目(No.13272704D)
CLC Number:
DONG Xiao-hua, MENG Xian-yong, ZHANG Li, YANG Jian-ming.Effects of Osthole on Neuronal Apoptosis and Cell Cycle in AD Rats[J]. Acta Neuropharmacologica, 2012, 2(3): 7-14.
| [1] Hernandez-Ortega Karina, Quiroz-Barz Ricardo, Arias Clorinda. Cell cycle reactivation in mature neurons: a link with brain plasticity, neu-ronal injury and neurodegenerative diseases [J]. Neurosci Bull, 2011, 27(3): 185-196. [2] Seth Love. Neuronal experssion of cell cycle-related proteins after brain ischaemia in man [J]. Neurosci Lett, 2003, 353(1): 29-32. [3] 李妍, 王海红, 董为人. 细胞周期重启与阿尔茨海默病[J]. 生命的化学2011, 31(4): 540-544. [4] 冷闻辉, 于明, 陈加俊, 等. MCI-186对阿尔茨海默病大鼠海马神经元细胞增殖和细胞周期的影响[J].中国实验诊断学, 2011, 13(3): 381-383. [5] Dong Xiao-Hua, Zhang Dan-Shen, Zhang Li. Osthole improves synaptic plasticity in the hippocampus and cognitive function of Alzheimer's disease rats via regulating glutamate[J]. Neural Regeneration Research, 2012, 7(30): 2325-2332. [6] 董晓华, 张丹参, 张力, 等. 蛇床子素对脑缺血再灌注大鼠海马LTP及氨基酸含量的影响 [J].中国药理学通报, 2011, 27(9): 1267-1271. [7] Jing Wei, Guo Fen, Cheng Li, et al. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo [J]. Neurosci Lett, 2009, 450(3): 306-310. [8] Yoshimasa Yamaguchi, Seiichiro Kawashima. Effects of amyloid-beta-(25-35) on passive avoidance, Radial-arm maze learning and choline acetyltransferase activity in the rat [J]. Eur J Pharmacol, 2001, 412(3): 265-272. [9] Nicholas J Rich, Jacob W Van Landingham, Silvia Figueiroa, et al. Chronic caloric restriction reduces tissue damage and improves spatial memory in a rat model of traumatic brain injury [J]. J Neurosci Res, 2010, 88(13): 2933-2939. [10] Zhang Wei-Wei, Sun Qi-Xin, Liu Yin-Hai, et al. Chronic administration of Liu Wei Dihuang protects rat’s brain against D-galactose-induced impairment of cholinergic system [J]. Acta Physiologica Sinica, 2011, 63(3): 245-255. [11] Gacar Nejat, Oguz Mutlu, Tijen Utkan, et al. Beneficial effects of resveratrol on scopolamine but not mecamylamine induced memory impairment in the passive avoidance and Morris water maze tests in rats. Pharmacology [J]. Biochemistry and Behavior, 2011, 99(3): 316-323. [12] Jovanovi? Z. Mechanisms of neurodegeneration in Alzheimer's disease [J]. Med Pregl, 2012, 65(7-8): 301-307. [13] Cui Shuke, Sun Yan, Liu Cheng-zang. Effect of bushenyisui formula on brain tissue apoptosis and Bcl-2 in beta-amyloid protein-induced Alzheimer's disease rat models [J]. J Tradit Chin Med, 2012, 32(4): 646-650. [14] Karl Herrup, Maria C Carrillo, Dale Schenk, et al. Beyond amyloid: getting real about nonamyloid targets in Alzheimer's disease [J]. Alzheimers Dement, 2013, 9(4): 452-458. [15] Misun Song, Young-Ah Kwon, Yujin Lee, et al. G1/S cell cycle checkpoint defect in lymphocytes from patients with Alzheimer's disease [J]. Psychiatry Investing, 2012, 9(4): 413-417. [16] Pavel Katsel, Tan Wei-lun, Fam Peter, et al. Cycle checkpoint abnormalities during dementia: a plausible association with the loss of protection against oxidative stress in Alzheimer's disease [J]. PLoS One, 2013, 8(7): e68361. [17] Ubaldo Armato, Balu Chakravarthy, Raffaella Pacchiana, et al. Alzheimer's disease: an update of the roles of receptors, astrocytes and primary cilia [J]. Int J Mol Med, 2013, 31(1): 3-10. [18] Seung Hwan Park, Soojin Lee, Yoon Ki Hong, et al. Suppressive effects of SuHeXiang Wan on amyloid-β42-induced extracellular signal-regulated kinase hyperactivation and glial cell proliferation in a transgenic Drosophila model of Alzheimer's disease [J]. Biol Pharm Bull, 2013, 36(3):390-398. [19] 郑立卿, 刘建华, 张丹参, 等. 蛇床子素在大鼠体内的药动学和组织靶向性研究[J].中国药理学通报, 2011, 27(4): 589-590. |
| [1] | LI Hui, YANG Jin-shui, XUE Qian.A Case of Huntington's Disease with Involuntary Movements of the Limbs as the First Symptom Combined with Dysarthria in the Early Stages of the Disease[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(6): 31-. |
| [2] | ZHANG Yuan-qing, LIN Yu, HUANG Li.Study on the Effects of Vitamin D on DNA Methylation in Alzheimer's Disease Cell Models[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(6): 39-. |
| [3] | ZHAO Yu-ting, YIN Hong-yan, GUO Chun-yan.Explore the Mechanism of Paeoniae Radix Alba Delaying Alzheimer's Disease Based on Network Pharmacology and Molecular Docking[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(5): 1-. |
| [4] | ZHANG Xin, YAO Si-fan, MA Meng-fan, SHEN Li-xia.Recent Progress in the Metabolomics of Alzheimer's Disease[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(5): 47-. |
| [5] | YAO Si-fan, ZHANG Xin, SHEN Li-xia.Effects of Tau Protein on Mitochondrial Function in Alzheimer's Disease[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(4): 54-. |
| [6] | WANG Tian-xu, LIU Ci, CUI Yong-yuan, ZHANG Xin, WU Miao-miao, SHEN Li-xia.Explore the Mechanism of Quercetin in the Treatment of Alzheimer's Disease by Network Pharmacology and Molecular Docking[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(2): 31-. |
| [7] | YIN Hong-yan, YOU Si-han, GUO Chun-yan.Research Progress of Core Markers and Other Markers of Alzheimer's Disease[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(6): 45-. |
| [8] | ZHU Jing-yi , FAN Jian-chun, YU Ai-mei.Research Status on the Neuroprotective Effect of Probucol[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(6): 50-. |
| [9] | .Exploring the Effect and Mechanism of Pterostilbene on Alzheimer’s Disease Based on Network Pharmacology[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(5): 1-. |
| [10] | BAI Jing-ru, YOU Si-han, YIN Hong-yan, YANG Song-rui, GUO Chun-yan.Predicting the Target of Peach Kernel in the Treatment of Parkinson's Disease Based on Network Pharmacology[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(3): 31-. |
| [11] | GUO Bao, LIU Zi-ming, JING Yong-shuai, ZHANG Dan-shen.Correlation Between Wnt Signaling Pathway and Alzheimer's Disease and Its Targets[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(1): 56-. |
| [12] | SI Wen-ying, HOU Yu-qing, SUN Xiao-jing, MENG Xian-yong, DONG Xiao-hua.Gene Therapy for Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(6): 51-56. |
| [13] | ZHANG Zhi-qing, ZHANG Yong-cai, LIU Lin-xuan, LI Ren-qing, LIU Ji-jia, DU Jing-kao, JIANG Bei, WEI Huiping, SU Li-ning.Bioinformatics Analysis of the Relationship between Exosomal ceRNA Regulatory Network and Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(4): 23-40. |
| [14] | CAI Yu-shan, ZHAO Shuai.Role of PPARβ/δ in Neurodegenerative Diseases[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(4): 41-48. |
| [15] | LV Xue-ying, ZHANG Zheng, LUO Huan-min.The Blood-Brain Barrier and Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(4): 58-64. |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||